yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
Red Hat
The Opening of Virtualization
User Environment Management – The Third Layer of the Desktop
Cloud Computing for Business Agility
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Return on Assests: Bringing Visibility to your SOA Strategy
Managing Hybrid Endpoint Environments
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
How Can AJAX Improve Homeland Security?
Beyond Widgets: What a RIA Platform Should Offer
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
Today's Top SOA Links

Free Research Reports on ACAD, ANTH, BPAX, VHC Issued by the Bedford Report
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

NEW YORK, NY -- (Marketwire) -- 11/26/12 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders. The company is on track to release results from their Phase III trial of pimavanserin in patients with Parkinson's disease psychosis later this month.

Find out more about ACADIA Pharmaceuticals including full access to the free equity report at:

Anthera Pharmaceuticals Inc. (NASDAQ: ANTH) shares of the biopharmaceutical company have fallen nearly 90 percent year-to-date. The company recently announced that that an abstract of the results from the Phase 2b PEARL-SC clinical study has been accepted as a late-breaking poster presentation at the ACR/ARHP 2012 Annual Scientific Meeting.

Find out more about Anthera Pharmaceuticals including full access to the free equity report at:

Biosante Pharmaceuticals Inc. (NASDAQ: BPAX) shares have fallen nearly 60 percent year-to-date. The company earlier this month announced that it has entered into a definitive merger agreement with ANI Pharmaceuticals, Inc., who had net sales of over $16 million in 2011.

Find out more about Biosante Pharmaceuticals including full access to the free equity report at:

VirnetX Holding Corporation (NYSE: VHC) shares surged earlier this month after it was reported that the company was awarded a large settlement. A jury has ordered Apple to pay the company $368 million.

Find out more about VirnetX including full access to the free equity report at:

Disclaimer: Equity News Circuit is not a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security. A third party, has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release.

Contact Information:

Equity News Circuit
Email Contact

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Web 2.0 Latest News
DevOps Summit at Cloud Expo 2014 Silicon Valley was a terrific event for us. The Qubell booth was crowded on all three days. We ran demos every 30 minutes with folks lining up to get a seat and usually standing around. It was great to meet and talk to over 500 people! My keynote was we...
Are you a winner? Are you someone who always gets what they want? Are you one of those people who do what they set their eyes on no matter what the circumstances? If you answered yes to all of these questions then you are among the highly successful people in the world that have a prov...
The iPad sales are down, but it is now possible to run most business apps on the iPad with the Citrix X1 Mouse. Can this make the iPad more relevant for business? Despite the mostly positive financial news from Apple, the one weakness that gets a lot of press is the decrease in iPad s...
Forbes called 2015, the Year of the Mobile Beacon. AdWeek talks about how beacons are already influencing the way we network, get drunk, vacation, shop, and even how we buy sausage. Ten experts at Marketing Land predicted that this year the whole world of mobile marketing will become ...
Ever wondered if your marketing efforts for an in-store sale or event are impacting, or even reaching, your customers? Foot traffic is a great indicator of marketing effectiveness. By comparing foot traffic before, during and after sale promotions you’re able to identify if any increas...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)!

Advertise on this site! Contact advertising(at)! 201 802-3021

SYS-CON Featured Whitepapers